Fresenius Kabi received a cybersecurity warning from the U.S. Government for its infusion pump system in which some components are susceptible to myriad security vulnerabilities.
The Food and Drug Administration on Wednesday issued an alert advising that the Cybersecurity and Infrastructure Security Agency is warning that a dozen vulnerabilities identified in certain components of Germany-based medical device manufacturer Fresenius Kabi’s Agilia Connect Infusion System pose a variety of security risks.
“Successful remote exploitation of these vulnerabilities could allow an attacker to gain access to sensitive information, modify settings, or perform arbitrary actions as an unauthorized user,” CISA says in its advisory.
The vulnerabilities, which have a low attack complexity, were identified by independent researchers who initially reported the flaws to the German Federal Office for Information Security, CISA notes.
Read the full article at Gov Info Security.
